Source:http://linkedlifedata.com/resource/pubmed/id/15256433
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
2004-7-16
|
pubmed:abstractText |
Perlecan, a modular proteoglycan carrying primary heparan sulfate (HS) side chains, is a major component of blood vessel basement membranes. It sequesters growth factors such as fibroblast growth factor 2 (FGF-2) and regulates the ligand-receptor interactions on the cell surface, and thus it has been implicated in the control of angiogenesis. Both stimulatory and inhibitory effects of perlecan on FGF-2 signaling have been reported. To understand the in vivo function of HS carried by perlecan, the perlecan gene heparan sulfate proteoglycan 2 (Hspg2) was mutated in mouse by gene targeting. The HS at the NH(2) terminus of perlecan was removed while the core protein remained intact. Perlecan HS-deficient (Hspg2(Delta3/Delta3)) mice survived embryonic development and were apparently healthy as adults. However, mutant mice exhibited significantly delayed wound healing, retarded FGF-2-induced tumor growth, and defective angiogenesis. In the mouse corneal angiogenesis model, FGF-2-induced neovascularization was significantly impaired in Hspg2(Delta3/Delta3) mutant mice. Our results suggest that HS in perlecan positively regulates the angiogenesis in vivo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4699-702
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15256433-Animals,
pubmed-meshheading:15256433-Basement Membrane,
pubmed-meshheading:15256433-Blood Vessels,
pubmed-meshheading:15256433-Cell Division,
pubmed-meshheading:15256433-Cornea,
pubmed-meshheading:15256433-Female,
pubmed-meshheading:15256433-Fibroblast Growth Factor 2,
pubmed-meshheading:15256433-Heparan Sulfate Proteoglycans,
pubmed-meshheading:15256433-Male,
pubmed-meshheading:15256433-Mice,
pubmed-meshheading:15256433-Mice, Inbred C57BL,
pubmed-meshheading:15256433-NIH 3T3 Cells,
pubmed-meshheading:15256433-Neoplasms, Experimental,
pubmed-meshheading:15256433-Neovascularization, Pathologic,
pubmed-meshheading:15256433-Neovascularization, Physiologic,
pubmed-meshheading:15256433-Transfection,
pubmed-meshheading:15256433-Wound Healing
|
pubmed:year |
2004
|
pubmed:articleTitle |
Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
|
pubmed:affiliation |
Department of Biochemistry, Faculty of Medicine, University of Hong Kong, 21 Sassoon Road, Hong Kong, ROC. zhongjun@hkucc.hku.hk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|